相关实验视频

Updated: Jul 20, 2025

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

儿科急性髓性白血病:洞察遗传格局和新的有针对性的方法

Natasa Tosic¹, Irena Marjanovic¹, Jelena Lazic²

¹Institute of Molecular Genetics and Genetic Engineering, Laboratory for Molecular Biomedicine, University of Belgrade, Serbia.

Biochemical pharmacology

|August 2, 2023

概括

新型向治疗对于改善儿科急性髓性白血病 (AML) 的结果至关重要,AML是一种异质癌症. 基因组学的进步揭示了精确的治疗策略和更好的患者生存的分子标.

科学领域:

血液学血液学血液学
儿科瘤学儿科瘤学
分子生物学分子生物学

背景情况:

急性髓性白血病 (AML) 是儿童癌症死亡的重要原因,尽管目前的治疗方法的生存率达到70%.
化疗和干细胞移植等标准疗法存在局限性,需要新的方法来获得更好的结果.
基因组学的进步揭示了儿科AML的分子复杂性,确定了潜在的治疗点.

研究的目的:

审查儿科AML的遗传情景.
探索分子特征化用于风险分层和向疗法开发的应用.
介绍针对儿科AML的向治疗和免疫疗法的最新进展.

主要方法:

关于儿科AML遗传学和向治疗的当前文献的综述.
对基因组数据的分析,以了解分子异质性.
对新型治疗策略的最新临床试验结果的综合.

主要成果:

儿科AML表现出显著的遗传异质性.
分子分析使得精确的患者分层和个性化治疗选择成为可能.
新兴的向疗法和免疫疗法显示出改善临床效益的前景.

结论:

了解儿科AML的遗传特征是开发有效治疗方法的关键.
向疗法和免疫疗法是改善儿科AML结果的前沿.
对分子机制的持续研究将推动进一步的治疗创新.

关键词:

急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.免疫治疗是一种免疫疗法.儿科儿科儿科有针对性的治疗.

更多相关视频

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...